These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6405286)

  • 1. MAO-B inhibitor deprenyl and beta-phenylethylamine potentiate [D-ALA2]-Met-enkephalinamide-induced seizures.
    Ukponmwan OE; van der Poel-Heisterkamp AL; Haffmans J; Dzoljic M
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb; 322(1):38-41. PubMed ID: 6405286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of repeated administration of (-) deprenyl on the phenylethylamine-induced stereotypy in rats.
    Timár J; Knoll B
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):50-60. PubMed ID: 3083795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine oxidation enhances opioid activity of an enkephalin analog.
    Kiritsy-Roy JA; Chan SK; Iwamoto ET
    Life Sci; 1983 Feb; 32(8):889-93. PubMed ID: 6131372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analgesic effect of enkephalinase inhibition is modulated by monoamine oxidase-B and REM sleep deprivations.
    Ukponmwan OE; Rupreht J; Dzoljic M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):376-9. PubMed ID: 3090452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonspecific convulsions are induced by morphine but not D-Ala2-methionine-enkephalinamide at cortical sites.
    Frenk H; Watkins LR; Miller J; Mayer DJ
    Brain Res; 1984 May; 299(1):51-9. PubMed ID: 6326965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylethylamine-induced stereotypies in the rat: a behavioral test system for assessment of MAO-B inhibitors.
    Ortmann R; Schaub M; Felner A; Lauber J; Christen P; Waldmeier PC
    Psychopharmacology (Berl); 1984; 84(1):22-7. PubMed ID: 6436886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N-methylamphetamine and deprenyl.
    Robinson JB
    Biochem Pharmacol; 1985 Dec; 34(23):4105-8. PubMed ID: 3933519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Ala2-Met-enkephalinamide, a potent opioid peptide, alters pituitary-adrenocortical secretion in rats.
    De Souza EB; Van Loon GR
    Endocrinology; 1982 Nov; 111(5):1483-90. PubMed ID: 6290184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.
    Paetsch PR; Greenshaw AJ
    Cell Mol Neurobiol; 1993 Jun; 13(3):203-15. PubMed ID: 8242685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [D-Ala2]-methionine enkephalinamide (DALA): characterization of antinociceptive, cardiovascular, and autonomic nervous system actions in conscious and pentobarbital-anesthetized rats.
    Randich A; Callahan MF
    Pharmacol Biochem Behav; 1986 Sep; 25(3):641-50. PubMed ID: 3774831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between enkephalin and dopamine in the control of locomotor activity in the rat: a new hypothesis.
    Agmo A; de Avila N
    Pharmacol Biochem Behav; 1985 Apr; 22(4):599-603. PubMed ID: 3991768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl].
    Yasar S; Justinova Z; Lee SH; Stefanski R; Goldberg SR; Tanda G
    J Pharmacol Exp Ther; 2006 Apr; 317(1):387-94. PubMed ID: 16352699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Met-enkephalin analog D-Ala2-Met-enkephalinamide decreases the adrenocortical response to ACTH in dispersed rat adrenal cells.
    Guaza C; Borrell J
    Peptides; 1984; 5(5):895-7. PubMed ID: 6095218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase-B inhibition: a comparison of in vivo and ex vivo measures of reversible effects.
    Turkish S; Yu PH; Greenshaw AJ
    J Neural Transm; 1988; 74(3):141-8. PubMed ID: 3145323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of MAO-B enzyme activity after (-)deprenyl (selegiline) pretreatment, measured in vivo.
    Timár J
    Acta Physiol Hung; 1989; 74(3-4):259-66. PubMed ID: 2517980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential behavioral effects induced by intrathecal microinjection of opiates: comparison of convulsive and cataleptic effects produced by morphine, methadone, and D-Ala2-methionine-enkephalinamide.
    Frenk H; Watkins LR; Mayer DJ
    Brain Res; 1984 May; 299(1):31-42. PubMed ID: 6326963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of stimulated lacrimal secretion by [D-Ala2]Met-enkephalinamide.
    Cripps MM; Patchen-Moor K
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G151-6. PubMed ID: 2546441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-phenylethylamine and benzylamine as substrates for human monoamine oxidase A: A source of some anomalies?
    Lewinsohn R; Glover V; Sandler M
    Biochem Pharmacol; 1980 Mar; 29(5):777-81. PubMed ID: 20227955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.